Essentialis Therapeutics' Acquisition

Essentialis Therapeutics was acquired by Capnia on December 27, 2016.

Essentialis Therapeutics is a privately-held clinical-stage biotechnology company focused on the development of medicines for the treatment of rare metabolic diseases where there is increased mortalit…

Articles about Essentialis Therapeutics' Acquisition: